Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers

Transplantation

Volumn 67, Issue 8, 1999, Pages 1119-1128

  Ierino, Francesco L ^a   Gojo, Satoshi ^a   Banerjee, Papia T ^b   Giovino, Maria ^b   Xu, Yuanxin ^b   Gere, John ^b   Kaynor, Cammy ^b   Awwad, Michel ^b   Monroy, Rodney ^b,c   Rembert, James ^a   Hatch, Tevis ^a   Foley, Alicia ^a   Kozlowski, Tomasz ^a   Yamada, Kazuhiko ^a   Neethling, Francisca A ^a   Fishman, Jay ^a   Bailin, Michael ^a   Spitzer, Thomas R ^a   Cooper, David K C ^a   Cosimi, A Benedict ^a   LeGuern, Christian ^a   Sachs, David H ^a   more..

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BioTransplant Inc   (United States)

^c Coulter Cellular Therapies ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; COBROTOXIN; COMPLEMENT COMPONENT C3B RECEPTOR; CYCLOSPORIN; GALACTOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; KANAMYCIN KINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BABOON; GENE TRANSFER; GENETIC TRANSCRIPTION; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY GRAFT; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN GRAFT; SPLENECTOMY; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSGENE; XENOGRAFT;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; PAPIO; SKIN TRANSPLANTATION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033609169     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904270-00006     Document Type: Article

References (51)

1. Sachs DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994; 43: 185.
2. Cooper DKC, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238.
3. Good AH, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
4. Platt JL, Bach FH. Mechanism of tissue injury in hyperacute xenograft rejection. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xenotransplantation. Heidelberg: Springer 1991; 69.
5. Alexandre GPJ, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy MA, ed. Xenograft 25. New York: Elsevier 1989: 259.
6. Cooper DKC. Depletion of natural antibodies in non-human primates: a step towards successful discordant xenografting in humans. Clin Transplant 1992; 6: 178.
7. Taniguchi S, Neethling FA, Korchagina EY, et al. In vivo immunoadsorption of anti-pig antibodies in baboons using a specific Galα1-3Gal column. Transplantation 1996; 62: 1379.
8. Kozlowski T, Ierino F, Lambrigts D, et al. Depletion of anti-Galα1-3Gal antibody in baboons by specific αGal immunoaffinity columns. Xenotransplantation 1998; 5: 122.
9. Kobayashi T, Taniguchi S, Neethling FA, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255.
10. Sandrin MS, Fodor WL, Mouhtouris E, et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1: 1261.
11. Thall AD, Maly P, Lowe JB. Oocyte Galα1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 1995; 270: 21437.
12. Tearle RG, Tange MJ, Zannettino ZL, et al. The α1,3-galactosyl-transferase knockout mouse: implications for xenotransplantation. Transplantation 1996; 61: 13.
13. Pruitt SK, Kirk AD, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.
14. White DJG, Langford GA, Cozzi E, Young VK. Production of pigs transgenic for human DAF: a strategy for xenotransplantation. Xenotransplantation 1995; 2: 213.
15. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1: 423.
16. Yang YG, deGoma E, Ohdan H, et al. Tolerization of anti-Galα-1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med 1998; 187: 1335.
17. Bracy JL, Sachs DH, Iacomini J. Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science. 1998; 281: 1845.
18. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
19. Auchincloss H Jr. Xenogeneic transplantation. Transplantation 1988; 46: 1.
20. Murray AG, Khodadoust MM, Pober JS, Bothwell AL. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57.
21. Yamada K, Sachs DH, DerSimonian H. Human anti-porcine xenogeneic T cell response: evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. J Immunol 1995; 155: 5249.
22. Sablinski T, Sachs DH. Xenotransplantation. In: Austen KF, Burakoff SJ, Rosen FS, Strom TB, eds. Therapeutic immunology. Cambridge, MA: Blackwell Science Inc, 1996: 529.
23. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493.
24. Sharabi Y, Aksentijevich I, Sundt TM III, Sachs DH, Sykes M. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.
25. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995; 59: 256.
26. Bartholomew AM, Cosimi AB, Sachs DH, et al. A study of tolerance in a concordant xenograft model. Transplant Proc 1997; 29: 923.
27. Madsen, JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1998; 332: 161.
28. Sykes M, Sachs DH, Nienhuis AW, Pearson DA, Moulton AD, Bodine DM. Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 1993; 55: 197.
29. Fraser CC, Sykes M, Lee RS, Sachs DH, LeGuern C. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway. J Immunol 1995; 154: 1587.
30. LeGuern C, Shimada H, Emery DW, Germana S, Shafer GE, Sachs DH. Retrovirus-mediated transfer of MHC class II cDNA into swine bone marrow cells. J Mol Med 1995; 73: 269.
31. Yasumoto A, Yamada K, Sablinski T, LeGuern C, Sykes M, Sachs DH. Mechanism of tolerance following class II gene transduction of autologous swine bone marrow. Transplant Proc 1997; 29: 1132.
32. Emery, DW, Sablinski T, Shimada, H, et al. Expression of an allogeneic MHC DRB transgene through retroviral transduction of bone marrow, induces specific reduction of alloreactivity. Transplantation 1997; 64: 1414.
33. Banerjee PT, Kaynor GC, Muthukumar S, et al. A polycistronic retrovirus vector for expression of swine MHC class II DRα/β heterodimer. Xenotransplantation 1997; 4.
34. Banerjee PT, Ierino FL, Kaynor GC, et al. Expression of swine MHC class II genes in a cynomolgus monkey: retrovirus mediated gene therapy in a preclinical transplantation model. Xenotransplantation 1997; 4: 174.
35. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980.
36. Sachs D.H. MHC Homozygous miniature swine. In: Swindle, M.M., Moody, D.C., Phillips, L.D., eds. Swine as models in biomedical research. Ames, IA: Iowa State University Press, 1992: 3.
37. Kozlowski T, Ierino FL, Fuchimoto Y, et al. Depletion of circulating anti-Galα 1-3Gal antibody in baboons by perfusion of specific immunoaffinity columns combined with apheresis. Xenotransplantation. 1998; 5: 122.
38. Sablinski T, Gianello PR, Bailin M, et al. Pig to monkey bone marrow and kidney xenotransplantation. Surgery 1997; 121: 381.
39. Banerjee P, Ahmad MF, Grove JR, Kozlosky C, Price DJ, Avruch J Molecular structure of a major insulin/mitogen-activated 70,000 dalton S6 protein kinase. Proc Natl Acad Sci USA 1990; 87: 8550.
40. Xu Y, Lorf T, Sablinski T. et al. Removal of anti-porcine natural antibodies from human and non-human primate plasma in vitro and in vivo by a Galα1-3Galβ1-4βGlc-X immunoaffinity column. Transplantation 1998; 65: 172.
41. Koren E, Neethling FA, Koscec M, et al. In vitro model for hyperacute rejection of xenogeneic cells. Transplant Proc 1994; 26: 1166.
42. Ierino FL, Kozlowski T, Siegel JB et al. Disseminated introvascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998; 66: 1439.
43. Sachs DH, Sablinski T. Tolerance across discordant xenogeneic barriers. Xenotransplantation 1995; 2: 234.
44. Sykes M; Lee LA; Sachs DH. Xenograft tolerance. Immunol Rev 1994; 141: 245.
45. Ramsdell F, Fowlkes BJ. Maintenance of in vivo tolerance by persistence of antigen. Science 1992; 257: 1130.
46. Sharabi Y, Abraham VS, Sykes M, Sachs DH. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplant 1992; 9: 191.
47. Van Beusechem VW, Valerio D. Gene transfer into hematopoietic stem cells of nonhuman primates. Hum Gene Ther 1996; 7:1649.
48. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 1995; 86: 101.
49. Challita PM, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 1994; 91: 2567.
50. Varmus HE, Padgett T, Heasley S, Simon G, Bishop JM. Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA. Cell 1977; 11: 307.
51. Schumacher IK, Newberg MH, Jackson JD, et al. Use of gene therapy to suppress the antigen-specific immune responses in mice to an HLA antigen. Transplantation 1996; 62: 831.